Joint Formulary & PAD

Pergolide - Parkinson's disease (neuroprotective therapy)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
NFD1
SPC
Restrictions / Comments :

Documentation

PAD Profile

ChemicalSubstance :
Pergolide
Indication :
Parkinson's disease (neuroprotective therapy)
Group Name :
Keywords :
dopamine agonists, non-ergot-derived dopamine receptor agonists, Parkinsons disease, PD
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Pergolide is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Parkinson's disease (neuroprotective therapy).

Committee Recommendations (1)

Dopamine agonists are not recommended as a neuroprotective therapy except in the context of a clinical trial